Lewis H. Bender - President and CEO, Director, 10%+ Owner at Intensity Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director, 10%+ Owner
Stock Symbol
INTS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lewis H. Bender since 12/24/2023

Holdings reported by Lewis H. Bender for Intensity Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.0001 Par Value 2M $8M $4.00 Jun 29, 2023 Direct
Stock Option (right to buy Common Stock) 33.6K Mar 6, 2024 Direct Common Stock

Transactions reported by Lewis H. Bender for Intensity Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.